All Insights
Showing 1 - 12 of 8542
IT and data
UK Cyber Security and Resilience Bill: pragmatic overhaul or regulatory overload?
The key changes and action points for businesses, and how the bill compares with the EU NIS2
The Digital Markets Competition and Consumers Act (DMCCA)
UK CMA finalises guidance on price transparency under DMCCA and begins enforcement action
From holidays to fashion, fourteen sectors under scrutiny as the regulator finalises guidance on total price requirements
Life Sciences and Healthcare
The US BIOSECURE Act: is your supply chain at risk?
The legislation could be enacted by the end of the year, with potentially wide-ranging consequences for biotech companies undertaking federal
Digital Regulation
Digital Omnibus reshapes EU cookie rules but leaves banner fatigue largely intact
The Digital Omnibus Proposal promises a cleaner, GDPR-based framework for cookies and consent, yet its narrow exemptions and technical fixes
Energy and Energy Transition
The Energy Transition | UK government consults on raft of changes to the Capacity Market
Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero
Life Sciences and Healthcare
EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026
First modules declared functional under phased approach, with vigilance and clinical studies still to follow
Workforce Solutions
Umbrella company tax reform has landed in the UK
The government's umbrella company tax reforms are now final and will take effect on 6 April 2026 – time to
Financial regulation
The EU's SFDR 2.0 – what do asset managers need to know?
The European Commission has published its proposals for a significant overhaul of the EU’s sustainable finance disclosure framework
Business crime
UK Serious Fraud Office publishes guidance on how it will evaluate corporate compliance programmes
SFO sets expectations on compliance, cooperation and failure to prevent fraud
Competition, antitrust and trade
New EU economic‑security roadmap resets the bar for foreign investment into Europe
European Commission tightens foreign investment scrutiny, with plans to monitor portfolio investments for the first time
Life Sciences and Healthcare
Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal
Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector
Knowledge Notes
UK Knowledge Collection | DSA and GDPR compliance, Life Sciences and the Budget, and managing contractual breach
Welcome to this week's Knowledge Collection
